Weight loss on a GLP-1 almost always slows down and then plateaus, usually somewhere between three and six months in. That happens because your body's calorie burn gradually catches down to how much less you're eating, a normal biological ceiling, not a sign that anything is broken or that the medication has quit working.

Why the scale stalls

Weight loss isn't linear, and a GLP-1 doesn't change that. As you lose weight, your body needs fewer calories to run itself day to day, so the same appetite effect that drove steady loss early on eventually just maintains where you are instead of pushing the number lower. In the STEP 1 trial, the largest randomized study of semaglutide for weight management, the average weight-loss curve visibly flattened out by around week 60, even while participants stayed on treatment the entire time. A plateau is what the curve is supposed to do eventually, not evidence of failure.

What counts as normal

A normal plateau looks like the scale holding steady, give or take a pound or two, for several weeks after a period of steady loss. Appetite may still feel quieter than before you started. Clothes usually still fit the same or looser, and energy and mood stay level. If that's your picture, the plateau is doing what plateaus do, and the work now is holding steady, not forcing the number lower through drastic changes.

It also helps to separate a real plateau from ordinary noise. A single flat week, or even a week where the number ticks up slightly, is usually water weight and normal day-to-day fluctuation rather than a genuine stall. The pattern that actually counts as a plateau is a trend that has been essentially flat for two to three consistent weeks, not a single reading that looked disappointing. Sodium intake, hormonal cycles, and even a heavier strength session can shift the scale by a pound or two in a day, none of which reflects anything about actual fat loss.

When it's not just a plateau

A few patterns are worth paying attention to instead of quietly riding out. If the scale is trending upward for more than two or three weeks in a row, if appetite has come back sharply and stayed loud, or if you're noticing new physical symptoms, that's a different situation than a plateau and worth a conversation with whoever manages your treatment. Tracking your weight as a trend line instead of a single daily number makes the difference between a normal plateau and a real shift much easier to see, and much less stressful to sit with in the meantime.

Three levers that still work

Three things keep moving the outcome even after the scale itself goes quiet for a while.

  • A daily protein floor. Hitting a minimum protein target every day protects the muscle you've already built and keeps you fuller between meals, without any calorie counting involved.
  • Short strength sessions. Two to four brief resistance sessions a week signal your body to hold onto muscle instead of losing it alongside fat, which matters more at a plateau than during the fast early drop.
  • Watching the trend, not the day. A single weigh-in bounces several pounds with water and food alone. A rolling trend line is what actually tells you whether a plateau is holding steady, drifting upward, or still slowly resolving on its own.

A plateau is what the weight-loss curve is supposed to do eventually. It's not evidence that anything has gone wrong.

Does the plateau look different by drug?

The general pattern, steady loss followed by a flattening curve, shows up across every GLP-1 studied so far, though the trial data suggests the timing and depth vary somewhat. In the STEP program, the semaglutide curve flattens around week 60, averaging close to 15 percent total loss. In the SURMOUNT program, the tirzepatide curve runs a similar shape but tends to flatten a bit later and a bit deeper, averaging closer to 20 percent for higher tiers by the same point. Neither pattern is better or worse, they're simply how each molecule's average response curve happens to be shaped across a large study population.

What matters for you personally is your own trend, not the population average from a trial. Some people plateau earlier than the average, some later, and both can be entirely normal. The population curve is useful for setting expectations in general terms, but it isn't a schedule your own body is required to follow. If your trend looks meaningfully different from what you expected going in, that's a reasonable thing to raise with your prescriber, not something to try to diagnose from a chart built on someone else's data.

When to loop in your prescriber

Anything about your treatment itself, whether it still feels right, whether something feels different, or any physical symptom worth mentioning, is a conversation for your prescriber, not something to work out from a blog post. What you can manage on your own is everything downstream of that: what you eat, how you move, and how closely you're watching the trend. That's the part this app is built for.

How OffRamp helps

OffRamp's Regain Radar turns your weigh-ins into a trend line instead of a noisy series of single numbers, so a normal plateau doesn't get mistaken for a real problem, or the other way around. Paired with a daily protein floor and short built-in strength sessions, it gives you the three levers that still work once the scale itself goes quiet, all in one place, free to download, no account required.